N. Gentile

Heightened COVID-19 Vaccine Response following SARS-CoV-2 Infection

S. Kelsen, A. Braverman, C. Rajput, 2021, medRxiv.

Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial

G. Felker, C. Lindsell, D. Boulware, 2022, medRxiv.

Effect of Ivermectin 600 mcg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial

C. Lindsell, D. Boulware, M. Sulkowski, 2022, medRxiv.

Study protocol for the Innovative Support for Patients with SARS-COV-2 Infections Registry (INSPIRE): A longitudinal study of the medium and long-term sequelae of SARS-CoV-2 infection

Bala N Hota, J. Elmore, R. Weinstein, 2021, medRxiv.

COVID-19 and related symptoms in patients under disulfiram for alcohol use disorder

Stefano Tamburin, Filippo Gori, E. Finotti, 2021, Internal and Emergency Medicine.

Association of Initial SARS-CoV-2 Test Positivity With Patient-Reported Well-being 3 Months After a Symptomatic Illness

Jin-Mann S. Lin, J. Elmore, R. Weinstein, 2022, JAMA network open.

Prevalence of Symptoms ≤12 Months After Acute Illness, by COVID-19 Testing Status Among Adults — United States, December 2020–March 2023

J. Elmore, R. Weinstein, G. Nichol, 2023, MMWR. Morbidity and mortality weekly report.